Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholder's Equity (Unaudited)

v3.22.0.1
Condensed Consolidated Statements of Changes in Stockholder's Equity (Unaudited) - USD ($)
$ in Thousands
Series C Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2020 $ 2 $ 186,559 $ (172,246) $ (5,610) $ 8,705
Beginning balance, shares at Mar. 31, 2020 1.55 1,777,483        
Stock based compensation related to common stock restricted stock grants 18 18
Stock based compensation related to common stock restricted stock grants, shares   3,086        
Stock based compensation, net of forfeitures 45 45
Issuance of common stock due to warrant exercises 1,490 1,490
Issuance of common stock due to warrant exercises, shares   169,167        
Conversion of Series C convertible preferred stock into common stock
Conversion of Series C convertible preferred stock into common stock, shares   17,222        
Foreign currency translation adjustment 167 167
Net loss 240 240
Ending balance, value at Jun. 30, 2020 $ 2 188,112 (172,006) (5,443) 10,665
Ending balance, shares at Jun. 30, 2020 1,966,958        
Stock based compensation, net of forfeitures 160 160
Issuance of common stock due to options exercises 429 429
Issuance of common stock due to options exercises, Shares   74,451        
Foreign currency translation adjustment 188 188
Net loss 120 120
Ending balance, value at Sep. 30, 2020 $ 2 188,701 (171,886) (5,255) 11,562
Ending balance, shares at Sep. 30, 2020 2,041,409        
Stock based compensation related to common stock options 90 90
Stock based compensation related to common stock restricted stock grants 3 3
Stock based compensation related to common stock restricted stock grants, shares   833        
Issuance of common stock due to options exercises 22 22
Issuance of common stock due to options exercises, Shares   5,000        
Issuance of common stock due to warrant exercises 269 269
Issuance of common stock due to warrant exercises, shares   31,817        
Foreign currency translation adjustment 1,020 1,020
Net loss (650) (650)
Ending balance, value at Dec. 31, 2020 $ 2 189,085 (172,536) (4,235) 12,316
Ending balance, shares at Dec. 31, 2020 2,079,059        
Beginning balance, value at Mar. 31, 2021 $ 2 189,217 (179,277) (4,579) 5,363
Beginning balance, shares at Mar. 31, 2021 2,092,909        
Conversion of Series C convertible preferred stock into common stock, shares (1.55)          
Transaction costs related to ATM agreement offering (10) (10)
Employee stock-based compensation expense 56 56
Stock based compensation related to issuance of restricted common stock 3 3
Foreign currency translation adjustment 307 307
Net loss (1,098) (1,098)
Ending balance, value at Jun. 30, 2021 $ 2 189,266 (180,375) (4,272) 4,621
Ending balance, shares at Jun. 30, 2021 2,092,909        
Beginning balance, value at Mar. 31, 2021 $ 2 189,217 (179,277) (4,579) 5,363
Beginning balance, shares at Mar. 31, 2021 2,092,909        
Ending balance, value at Dec. 31, 2021 $ 3 197,156 (181,419) (4,571) 11,169
Ending balance, shares at Dec. 31, 2021 3,099,341        
Beginning balance, value at Jun. 30, 2021 $ 2 189,266 (180,375) (4,272) 4,621
Beginning balance, shares at Jun. 30, 2021 2,092,909        
Issuance of common stock in connection with ATM, net of transaction costs $ 1 6,901 6,902
Issuance of common stock in connection with ATM, net of transaction costs, Shares   855,500        
Issuance of common stock due to options exercises 193 193
Issuance of common stock due to options exercises, Shares   44,042        
Issuance of common stock due to warrant exercises 23 23
Issuance of common stock due to warrant exercises, shares   12,290        
Employee stock-based compensation expense 52 52
Stock based compensation related to issuance of restricted common stock 3 3
Foreign currency translation adjustment (234) (234)
Net loss (100) (100)
Ending balance, value at Sep. 30, 2021 $ 3 196,438 (180,475) (4,506) 11,460
Ending balance, shares at Sep. 30, 2021 3,004,741        
Shares issued in connection with ATM, net of transaction costs 662 662
Shares issued in connection with ATM, net of transaction costs, shares   94,600        
Employee stock-based compensation expense 56 56
Foreign currency translation adjustment (65) (65)
Net loss (944) (944)
Ending balance, value at Dec. 31, 2021 $ 3 $ 197,156 $ (181,419) $ (4,571) $ 11,169
Ending balance, shares at Dec. 31, 2021 3,099,341